Myocardin Sumoylation Transactivates Cardiogenic Genes in Pluripotent 10T1/2 Fibroblasts

REFERENCES

• Aravind, L., and E. V. Koonin. 2000. SAP—a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25:112–114.
   PubMed Web of Science ®Google Scholar
• Arora, T., B. Liu, H. He, J. Kim, T. L. Murphy, K. M. Murphy, R. L. Modlin, and K. Shuai. 2003. PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4. J. Biol. Chem. 278:21327–21330.
   PubMed Web of Science ®Google Scholar
• Belaguli, N. S., J. L. Sepulveda, V. Nigam, F. Charron, M. Nemer, and R. J. Schwartz. 2000. Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol. Cell. Biol. 20:7550–7558.
   PubMedGoogle Scholar
• Cao, D., Z. Wang, C. L. Zhang, J. Oh, W. Xing, S. Li, J. A. Richardson, D. Z. Wang, and E. N. Olson. 2005. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25:364–376.
   PubMedGoogle Scholar
• Chang, D. F., N. S. Belaguli, D. Iyer, W. B. Roberts, S. P. Wu, X. R. Dong, J. G. Marx, M. S. Moore, M. C. Beckerle, M. W. Majesky, and R. J. Schwartz. 2003. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 4:107–118.
   PubMed Web of Science ®Google Scholar
• Chang, J., L. Wei, T. Otani, K. A. Youker, M. L. Entman, and R. J. Schwartz. 2003. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation 108:407–413.
   PubMed Web of Science ®Google Scholar
• Chen, A., H. Mannen, and S. S. Li. 1998. Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/pseudogenes. Biochem. Mol. Biol. Int. 46:1161–1174.
   PubMedGoogle Scholar
• Chen, J., C. M. Kitchen, J. W. Streb, and J. M. Miano. 2002. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 34:1345–1356.
   PubMedGoogle Scholar
• Chi, N. C., and J. S. Karliner. 2004. Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc. Res. 61:437–447.
   PubMedGoogle Scholar
• Chung, C. D., J. Liao, B. Liu, X. Rao, P. Jay, P. Berta, and K. Shuai. 1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803–1805.
   PubMed Web of Science ®Google Scholar
• Collavin, L., M. Gostissa, F. Avolio, P. Secco, A. Ronchi, C. Santoro, and G. Del Sal. 2004. Modification of the erythroid transcription factor GATA-1 by SUMO-1. Proc. Natl. Acad. Sci. USA 101:8870–8875.
   PubMedGoogle Scholar
• Du, K. L., H. S. Ip, J. Li, M. Chen, F. Dandre, W. Yu, M. M. Lu, G. K. Owens, and M. S. Parmacek. 2003. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell. Biol. 23:2425–2437.
   PubMed Web of Science ®Google Scholar
• Gill, G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18:2046–2059.
   PubMed Web of Science ®Google Scholar
• Girdwood, D., D. Bumpass, O. A. Vaughan, A. Thain, L. A. Anderson, A. W. Snowden, E. Garcia-Wilson, N. D. Perkins, and R. T. Hay. 2003. P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11:1043–1054.
   PubMedGoogle Scholar
• Gross, M., R. Yang, I. Top, C. Gasper, and K. Shuai. 2004. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene 23:3059–3066.
   PubMed Web of Science ®Google Scholar
• Guo, D., M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R. H. Podolsky, A. Muir, J. Wang, Z. Dong, T. Brusko, M. Atkinson, P. Pozzilli, A. Zeidler, L. J. Raffel, C. O. Jacob, Y. Park, M. Serrano-Rios, M. T. Larrad, Z. Zhang, H. J. Garchon, J. F. Bach, J. I. Rotter, J. X. She, and C. Y. Wang. 2004. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat. Genet. 36:837–841.
   PubMed Web of Science ®Google Scholar
• Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell 18:1–12.
   PubMed Web of Science ®Google Scholar
• Hayashi, T., M. Seki, D. Maeda, W. Wang, Y. Kawabe, T. Seki, H. Saitoh, T. Fukagawa, H. Yagi, and T. Enomoto. 2002. Ubc9 is essential for viability of higher eukaryotic cells. Exp. Cell Res. 280:212–221.
   PubMedGoogle Scholar
• Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053–3058.
   PubMedGoogle Scholar
• Kagey, M. H., T. A. Melhuish, and D. Wotton. 2003. The polycomb protein Pc2 is a SUMO E3. Cell 113:127–137.
   PubMed Web of Science ®Google Scholar
• Kahyo, T., T. Nishida, and H. Yasuda. 2001. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8:713–718.
   PubMed Web of Science ®Google Scholar
• Kawai-Kowase, K., M. S. Kumar, M. H. Hoofnagle, T. Yoshida, and G. K. Owens. 2005. PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol. Cell. Biol. 25:8009–8023.
   PubMedGoogle Scholar
• Kirsh, O., J. S. Seeler, A. Pichler, A. Gast, S. Muller, E. Miska, M. Mathieu, A. Harel-Bellan, T. Kouzarides, F. Melchior, and A. Dejean. 2002. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21:2682–2691.
   PubMed Web of Science ®Google Scholar
• Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:5222–5234.
   PubMed Web of Science ®Google Scholar
• Lapenta, V., P. Chiurazzi, P. van der Spek, A. Pizzuti, F. Hanaoka, and C. Brahe. 1997. SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. Genomics 40:362–366.
   PubMedGoogle Scholar
• Lee, H., J. C. Quinn, K. V. Prasanth, V. A. Swiss, K. D. Economides, M. M. Camacho, D. L. Spector, and C. Abate-Shen. 2006. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev. 20:784–794.
   PubMedGoogle Scholar
• Lee, Y. S., M. S. Jang, J. S. Lee, E. J. Choi, and E. Kim. 2005. SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. EMBO Rep. 6:949–955.
   PubMedGoogle Scholar
• Li, S., D. Z. Wang, Z. Wang, J. A. Richardson, and E. N. Olson. 2003. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. USA 100:9366–9370.
   PubMed Web of Science ®Google Scholar
• Liang, M., F. Melchior, X. H. Feng, and X. Lin. 2004. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1. J. Biol. Chem. 279:22857–22865.
   PubMedGoogle Scholar
• Liang, Q., L. J. De Windt, S. A. Witt, T. R. Kimball, B. E. Markham, and J. D. Molkentin. 2001. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 276:30245–30253.
   PubMed Web of Science ®Google Scholar
• Lin, X., M. Liang, Y. Y. Liang, F. C. Brunicardi, F. Melchior, and X. H. Feng. 2003. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J. Biol. Chem. 278:18714–18719.
   PubMed Web of Science ®Google Scholar
• Lin, X., B. Sun, M. Liang, Y. Y. Liang, A. Gast, J. Hildebrand, F. C. Brunicardi, F. Melchior, and X. H. Feng. 2003. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol. Cell 11:1389–1396.
   PubMedGoogle Scholar
• Liu, B., M. Gross, J. ten Hoeve, and K. Shuai. 2001. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc. Natl. Acad. Sci. USA 98:3203–3207.
   PubMedGoogle Scholar
• Liu, B., J. Liao, X. Rao, S. A. Kushner, C. D. Chung, D. D. Chang, and K. Shuai. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95:10626–10631.
   PubMed Web of Science ®Google Scholar
• Long, J., I. Matsuura, D. He, G. Wang, K. Shuai, and F. Liu. 2003. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc. Natl. Acad. Sci. USA 100:9791–9796.
   PubMedGoogle Scholar
• Matsuzaki, K., T. Minami, M. Tojo, Y. Honda, Y. Uchimura, H. Saitoh, H. Yasuda, S. Nagahiro, H. Saya, and M. Nakao. 2003. Serum response factor is modulated by the SUMO-1 conjugation system. Biochem. Biophys. Res. Commun. 306:32–38.
   PubMed Web of Science ®Google Scholar
• Melchior, F. 2000. SUMO-nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16:591–626.
   PubMed Web of Science ®Google Scholar
• Muller, S., C. Hoege, G. Pyrowolakis, and S. Jentsch. 2001. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2:202–210.
   PubMed Web of Science ®Google Scholar
• Nacerddine, K., F. Lehembre, M. Bhaumik, J. Artus, M. Cohen-Tannoudji, C. Babinet, P. P. Pandolfi, and A. Dejean. 2005. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9:769–779.
   PubMed Web of Science ®Google Scholar
• Nakagawa, K., and N. Kuzumaki. 2005. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification. Genes Cells 10:835–850.
   PubMedGoogle Scholar
• Narita, N., M. Bielinska, and D. B. Wilson. 1997. Wild-type endoderm abrogates the ventral developmental defects associated with GATA-4 deficiency in the mouse. Dev. Biol. 189:270–274.
   PubMedGoogle Scholar
• Niu, Z., W. Yu, S. X. Zhang, M. Barron, N. S. Belaguli, M. D. Schneider, M. Parmacek, A. Nordheim, and R. J. Schwartz. 2005. Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets. J. Biol. Chem. 280:32531–32538.
   PubMed Web of Science ®Google Scholar
• Oh, J., Z. Wang, D. Z. Wang, C. L. Lien, W. Xing, and E. N. Olson. 2004. Target gene-specific modulation of myocardin activity by GATA transcription factors. Mol. Cell. Biol. 24:8519–8528.
   PubMedGoogle Scholar
• Pichler, A., A. Gast, J. S. Seeler, A. Dejean, and F. Melchior. 2002. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108:109–120.
   PubMed Web of Science ®Google Scholar
• Prigge, J. R., and E. E. Schmidt. 2006. Interaction of protein inhibitor of activated STAT (PIAS) proteins with the TATA-binding protein, TBP. J. Biol. Chem. 281:12260–12269.
   PubMedGoogle Scholar
• Riquelme, C., K. K. Barthel, X. F. Qin, and X. Liu. 2006. Ubc9 expression is essential for myotube formation in C2C12. Exp. Cell Res. 312:2132–2141.
   PubMedGoogle Scholar
• Rodriguez, M. S., C. Dargemont, and R. T. Hay. 2001. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:12654–12659.
   PubMed Web of Science ®Google Scholar
• Roy Chowdhuri, S., T. Crum, A. Woollard, S. Aslam, and P. G. Okkema. 2006. The T-box factor TBX-2 and the SUMO conjugating enzyme UBC-9 are required for ABa-derived pharyngeal muscle in C. elegans. Dev. Biol. 295:664–677.
   PubMed Web of Science ®Google Scholar
• Saitoh, H., and J. Hinchey. 2000. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275:6252–6258.
   PubMed Web of Science ®Google Scholar
• Sepulveda, J. L., S. Vlahopoulos, D. Iyer, N. Belaguli, and R. J. Schwartz. 2002. Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J. Biol. Chem. 277:25775–25782.
   PubMedGoogle Scholar
• Shao, R., F. P. Zhang, F. Tian, P. Anders Friberg, X. Wang, H. Sjoland, and H. Billig. 2004. Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1alpha in adult mouse brain and heart in vivo. FEBS Lett. 569:293–300.
   PubMed Web of Science ®Google Scholar
• Tashiro, K., M. P. Pando, Y. Kanegae, P. M. Wamsley, S. Inoue, and I. M. Verma. 1997. Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha. Proc. Natl. Acad. Sci. USA 94:7862–7867.
   PubMed Web of Science ®Google Scholar
• Ueyama, T., H. Kasahara, T. Ishiwata, Q. Nie, and S. Izumo. 2003. Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis. Mol. Cell. Biol. 23:9222–9232.
   PubMedGoogle Scholar
• van Tuyn, J., S. Knaan-Shanzer, M. J. van de Watering, M. de Graaf, A. van der Laarse, M. J. Schalij, E. E. van der Wall, A. A. de Vries, and D. E. Atsma. 2005. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc. Res. 67:245–255.
   PubMed Web of Science ®Google Scholar
• Wang, D., P. S. Chang, Z. Wang, L. Sutherland, J. A. Richardson, E. Small, P. A. Krieg, and E. N. Olson. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851–862.
   PubMed Web of Science ®Google Scholar
• Wang, D. Z., S. Li, D. Hockemeyer, L. Sutherland, Z. Wang, G. Schratt, J. A. Richardson, A. Nordheim, and E. N. Olson. 2002. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. USA 99:14855–14860.
   PubMed Web of Science ®Google Scholar
• Wang, J., X. H. Feng, and R. J. Schwartz. 2004. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity. J. Biol. Chem. 279:49091–49098.
   PubMed Web of Science ®Google Scholar
• Wang, Z., D. Z. Wang, G. C. Pipes, and E. N. Olson. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. USA 100:7129–7134.
   PubMed Web of Science ®Google Scholar
• Yoshida, T., K. Kawai-Kowase, and G. K. Owens. 2004. Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler. Thromb. Vasc. Biol. 24:1596–1601.
   PubMedGoogle Scholar